Imagine a world where HIV prevention is not just effective, but also equitable and accessible to all. This is the bold vision driving the People’s Research Agenda (PRA), a groundbreaking initiative launched in 2024 in collaboration with global advocates and communities. But here’s where it gets controversial: while scientific advancements have brought us closer to ending HIV, the pace of progress isn’t uniform, and many populations are still left behind. The PRA steps in to address this gap by offering a people-centered framework that accelerates research and development (R&D) and ensures new prevention products are introduced fairly and swiftly.
At its core, the PRA acts as a watchdog and a roadmap. It meticulously tracks scientific progress, highlights where investments align with community-defined priorities, and—crucially—exposes where they fall short. And this is the part most people miss: the pipeline of prevention options is riddled with gaps, failing to meet the diverse needs of all populations. From long-acting injectables to microbicides, the PRA spotlights what’s missing and what’s urgently needed.
Featuring insights from Jeanne Marrazzo, former Director of the National Institute of Allergy and Infectious Diseases and AVAC board member, this agenda isn’t just a document—it’s a call to action. We’ll explore what the PRA tracks, why it’s a game-changer for HIV prevention, and the advocacy priorities that will shape the future of R&D. For instance, did you know that while PrEP (pre-exposure prophylaxis) has been a game-changer, its accessibility remains limited in low-resource settings? The PRA aims to tackle such disparities head-on.
Here’s a thought-provoking question for you: In a world where science can seemingly conquer anything, why do inequities in HIV prevention persist? Is it a matter of funding, political will, or something deeper? The PRA invites us to confront these questions and demands a collective effort to bridge the gap between innovation and equity. Let’s not just imagine a better future—let’s build it together. Share your thoughts in the comments: What do you think is the biggest barrier to equitable HIV prevention, and how can we overcome it?
